What is Simian Virus 40 (SV40) in poliovirus vaccines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is SV40 in Vaccines?

SV40 (Simian Virus 40) was an inadvertent contaminant of early poliovirus vaccines produced between 1955 and early 1963, originating from monkey kidney cell cultures used in vaccine production, but modern polio vaccines manufactured after 1963 do not contain SV40. 1, 2, 3

Historical Context of SV40 Contamination

SV40 is a polyomavirus naturally found in rhesus macaque monkeys that was discovered in 1960 as a contaminant in both inactivated (IPV) and oral (OPV) poliovirus vaccines. 2, 3 The contamination occurred because:

  • Early vaccine production used primary monkey kidney cell cultures from rhesus macaques that harbored this previously unknown virus 2, 3
  • Millions of people received SV40-contaminated vaccines between 1955 and early 1963 before the contamination was identified and eliminated 2, 3
  • The virus was eliminated from vaccine production after 1963 by using monkeys bred in isolated colonies and implementing better screening methods 4

Current Vaccine Safety Status

Modern poliovirus vaccines do not contain SV40. The currently licensed IPV products in the United States are:

  • IPOL®: Grown on Vero cells (continuous monkey kidney cell line) using the microcarrier method, with no SV40 contamination 1
  • POLIOVAX®: Grown on human diploid (MRC-5) cell cultures, eliminating any risk of simian virus contamination 1

Testing of 12 current poliovaccine vials uniformly showed negative results for SV40, confirming that modern production methods using isolated monkey colonies and improved screening have prevented contamination. 4

Clinical Significance and Cancer Risk

Large epidemiologic studies have not identified elevated cancer risk in persons who received SV40-contaminated vaccines, despite SV40 being a known tumor virus in laboratory animals. 2, 5, 6

Key findings from follow-up studies:

  • A 35-year follow-up of 1,073 persons who received SV40-contaminated vaccines as newborns found no increased overall cancer mortality (4 deaths observed vs. 3.16 expected) 5
  • A case-control study of US Army veterans exposed to SV40-contaminated adenovirus vaccine found no association with brain tumors (OR 0.81), mesothelioma (OR 1.41), or non-Hodgkin's lymphoma (OR 0.97) 6
  • While SV40 DNA fragments have been detected in some human tumors by certain laboratories, epidemiologic evidence does not support a causative role 2, 6

Important Caveats

The detection of SV40 in historical vaccines does not affect current vaccination recommendations. Modern IPV is the only recommended polio vaccine in the United States and is completely safe from SV40 contamination. 1, 7

For patients concerned about historical SV40 exposure:

  • No special screening or monitoring is recommended for individuals who may have received contaminated vaccines, as epidemiologic data does not support increased cancer risk 5, 6
  • Current vaccines pose no SV40 risk and should be administered according to standard CDC/ACIP schedules 1, 7
  • The switch to IPV in 2000 was made to eliminate vaccine-associated paralytic polio (VAPP), not due to SV40 concerns 1, 8, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Polio Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Vaccine-Associated Paralytic Polio (VAPP)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.